518 related articles for article (PubMed ID: 16046395)
21. Association of single nucleotide polymorphisms of ABCB1, OPRM1 and COMT with pain perception in cancer patients.
Wang XS; Song HB; Chen S; Zhang W; Liu JQ; Huang C; Wang HR; Chen Y; Chu Q
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):752-758. PubMed ID: 26489634
[TBL] [Abstract][Full Text] [Related]
22. The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease.
Klepstad P; Rakvåg TT; Kaasa S; Holthe M; Dale O; Borchgrevink PC; Baar C; Vikan T; Krokan HE; Skorpen F
Acta Anaesthesiol Scand; 2004 Nov; 48(10):1232-9. PubMed ID: 15504181
[TBL] [Abstract][Full Text] [Related]
23. Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts.
Schwantes-An TH; Zhang J; Chen LS; Hartz SM; Culverhouse RC; Chen X; Coon H; Frank J; Kamens HM; Konte B; Kovanen L; Latvala A; Legrand LN; Maher BS; Melroy WE; Nelson EC; Reid MW; Robinson JD; Shen PH; Yang BZ; Andrews JA; Aveyard P; Beltcheva O; Brown SA; Cannon DS; Cichon S; Corley RP; Dahmen N; Degenhardt L; Foroud T; Gaebel W; Giegling I; Glatt SJ; Grucza RA; Hardin J; Hartmann AM; Heath AC; Herms S; Hodgkinson CA; Hoffmann P; Hops H; Huizinga D; Ising M; Johnson EO; Johnstone E; Kaneva RP; Kendler KS; Kiefer F; Kranzler HR; Krauter KS; Levran O; Lucae S; Lynskey MT; Maier W; Mann K; Martin NG; Mattheisen M; Montgomery GW; Müller-Myhsok B; Murphy MF; Neale MC; Nikolov MA; Nishita D; Nöthen MM; Nurnberger J; Partonen T; Pergadia ML; Reynolds M; Ridinger M; Rose RJ; Rouvinen-Lagerström N; Scherbaum N; Schmäl C; Soyka M; Stallings MC; Steffens M; Treutlein J; Tsuang M; Wall TL; Wodarz N; Yuferov V; Zill P; Bergen AW; Chen J; Cinciripini PM; Edenberg HJ; Ehringer MA; Ferrell RE; Gelernter J; Goldman D; Hewitt JK; Hopfer CJ; Iacono WG; Kaprio J; Kreek MJ; Kremensky IM; Madden PA; McGue M; Munafò MR; Philibert RA; Rietschel M; Roy A; Rujescu D; Saarikoski ST; Swan GE; Todorov AA; Vanyukov MM; Weiss RB; Bierut LJ; Saccone NL
Behav Genet; 2016 Mar; 46(2):151-69. PubMed ID: 26392368
[TBL] [Abstract][Full Text] [Related]
24. Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty.
Chou WY; Yang LC; Lu HF; Ko JY; Wang CH; Lin SH; Lee TH; Concejero A; Hsu CJ
Acta Anaesthesiol Scand; 2006 Aug; 50(7):787-92. PubMed ID: 16879459
[TBL] [Abstract][Full Text] [Related]
25. A genetic association study of the functional A118G polymorphism of the human mu-opioid receptor gene in patients with acute and chronic pain.
Janicki PK; Schuler G; Francis D; Bohr A; Gordin V; Jarzembowski T; Ruiz-Velasco V; Mets B
Anesth Analg; 2006 Oct; 103(4):1011-7. PubMed ID: 17000822
[TBL] [Abstract][Full Text] [Related]
26. A systematic review of the A118G (Asn40Asp) variant of OPRM1 in relation to smoking initiation, nicotine dependence and smoking cessation.
Verhagen M; Kleinjan M; Engels RC
Pharmacogenomics; 2012 Jun; 13(8):917-33. PubMed ID: 22676196
[TBL] [Abstract][Full Text] [Related]
27. Study of the OPRM1 A118G genetic polymorphism associated with postoperative nausea and vomiting induced by fentanyl intravenous analgesia.
Zhang W; Yuan JJ; Kan QC; Zhang LR; Chang YZ; Wang ZY
Minerva Anestesiol; 2011 Jan; 77(1):33-9. PubMed ID: 21150856
[TBL] [Abstract][Full Text] [Related]
28. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.
Bond C; LaForge KS; Tian M; Melia D; Zhang S; Borg L; Gong J; Schluger J; Strong JA; Leal SM; Tischfield JA; Kreek MJ; Yu L
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9608-13. PubMed ID: 9689128
[TBL] [Abstract][Full Text] [Related]
29. Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism.
Browne CA; Erickson RL; Blendy JA; Lucki I
Neuropharmacology; 2017 May; 117():401-407. PubMed ID: 28188737
[TBL] [Abstract][Full Text] [Related]
30. Expansion of the human mu-opioid receptor gene architecture: novel functional variants.
Shabalina SA; Zaykin DV; Gris P; Ogurtsov AY; Gauthier J; Shibata K; Tchivileva IE; Belfer I; Mishra B; Kiselycznyk C; Wallace MR; Staud R; Spiridonov NA; Max MB; Goldman D; Fillingim RB; Maixner W; Diatchenko L
Hum Mol Genet; 2009 Mar; 18(6):1037-51. PubMed ID: 19103668
[TBL] [Abstract][Full Text] [Related]
31. Mouse model of OPRM1 (A118G) polymorphism has altered hippocampal function.
Mague SD; Port RG; McMullen ME; Carlson GC; Turner JR
Neuropharmacology; 2015 Oct; 97():426-35. PubMed ID: 25986698
[TBL] [Abstract][Full Text] [Related]
32. A functional polymorphism of the mu-opioid receptor gene (OPRM1) influences cue-induced craving for alcohol in male heavy drinkers.
van den Wildenberg E; Wiers RW; Dessers J; Janssen RG; Lambrichs EH; Smeets HJ; van Breukelen GJ
Alcohol Clin Exp Res; 2007 Jan; 31(1):1-10. PubMed ID: 17207095
[TBL] [Abstract][Full Text] [Related]
33. Genetic-epigenetic interaction modulates μ-opioid receptor regulation.
Oertel BG; Doehring A; Roskam B; Kettner M; Hackmann N; Ferreirós N; Schmidt PH; Lötsch J
Hum Mol Genet; 2012 Nov; 21(21):4751-60. PubMed ID: 22875838
[TBL] [Abstract][Full Text] [Related]
34. Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence.
Franke P; Wang T; Nöthen MM; Knapp M; Neidt H; Albrecht S; Jahnes E; Propping P; Maier W
Am J Med Genet; 2001 Jan; 105(1):114-9. PubMed ID: 11424981
[TBL] [Abstract][Full Text] [Related]
35. Implication of OPRM1 A118G Polymorphism in Opioids Addicts in Pakistan: In vitro and In silico Analysis.
Ahmed M; Ul Haq I; Faisal M; Waseem D; Taqi MM
J Mol Neurosci; 2018 Aug; 65(4):472-479. PubMed ID: 30033503
[TBL] [Abstract][Full Text] [Related]
36. Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers.
Ray R; Ruparel K; Newberg A; Wileyto EP; Loughead JW; Divgi C; Blendy JA; Logan J; Zubieta JK; Lerman C
Proc Natl Acad Sci U S A; 2011 May; 108(22):9268-73. PubMed ID: 21576462
[TBL] [Abstract][Full Text] [Related]
37. Genomic variations and transcriptional regulation of the human mu-opioid receptor gene.
Bayerer B; Stamer U; Hoeft A; Stüber F
Eur J Pain; 2007 May; 11(4):421-7. PubMed ID: 16843022
[TBL] [Abstract][Full Text] [Related]
38. A common single nucleotide polymorphism A118G of the μ opioid receptor alters its N-glycosylation and protein stability.
Huang P; Chen C; Mague SD; Blendy JA; Liu-Chen LY
Biochem J; 2012 Jan; 441(1):379-86. PubMed ID: 21864297
[TBL] [Abstract][Full Text] [Related]
39. Oprm1 A112G, a single nucleotide polymorphism, alters expression of stress-responsive genes in multiple brain regions in male and female mice.
Collins D; Randesi M; da Rosa JC; Zhang Y; Kreek MJ
Psychopharmacology (Berl); 2018 Sep; 235(9):2703-2711. PubMed ID: 30027498
[TBL] [Abstract][Full Text] [Related]
40. Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures.
Peciña M; Love T; Stohler CS; Goldman D; Zubieta JK
Neuropsychopharmacology; 2015 Mar; 40(4):957-65. PubMed ID: 25308352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]